{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anxiety", "epilepsy", "etnopharmacology", "flavonoid", "glutamate", "\u03b3 - aminobutyric acid (GABA)"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32848784", "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "11"}], "Language": ["eng"], "ELocationID": ["1181", "10.3389/fphar.2020.01181"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Vitexin Possesses Anticonvulsant and Anxiolytic-Like Effects in Murine Animal Models.", "Pagination": {"StartPage": "1181", "MedlinePgn": "1181"}, "Abstract": {"AbstractText": ["Different types of epilepsy and forms of pathological anxiety have been described as significant neurological disorders that may exist as comorbidities. Some of those disorders share the association of affected limbic areas/neuropathological triggers as well as the use of drugs for their clinical management. The aim of this work was to investigate the anticonvulsant and anxiolytic properties of the vitexin (apigenin-8-C-glucoside), since this compound is a flavonoid usually found as one of the major constituents in several medicinal plants claimed as anxiolytics and/or anticonvulsants. This investigation was performed by the use of a series of classical murine animal models of chemically induced-seizures and of anxiety-related tests (open-field, elevated plus-maze, and light-dark box tests). Here, we show that the systemic administration of vitexin (1.25; 2.5 and 5 mg/kg; i.p.) exhibited selective protection against chemically-induced seizures. Vitexin did not block seizures evoked by glutamate receptors agonists (NMDA and kainic acid), and it did not interfere with the latencies for these seizures. Conversely, the same treatments protected the animals in a dose-dependent manner against the seizures evoked by the Gabaergic antagonists picrotoxin and PTZ and rise the latency time for the first seizure on non-protected animals. The higher dose of vitexin protected 100% of animals against the tonic-clonic seizures triggered by GABA antagonists. The results from open-field, elevated plus-maze, and light-dark box tests indicated the anxiolytic properties of vitexin at similar range of doses described for the anticonvulsant action screening. Furthermore, these results pointed that vitexin did not cause sedation or locomotor impairment on animals. The selective action of vitexin against picrotoxin and PTZ may reinforce the hypothesis by which this compound acts mainly by the modulation of GABAergic neurotransmission and/or related pathways. This could be useful to explain the dual activity of vitexin as anticonvulsant and anxiolytic, and highlight the pharmacological interest on this promising flavonoid."], "CopyrightInformation": "Copyright \u00a9 2020 de Oliveira, da Silva, Iglesias and Beleboni."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Ribeir\u00e3o Preto, Ribeir\u00e3o Preto, Brazil."}], "LastName": "de Oliveira", "ForeName": "Denise Dias", "Initials": "DD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Ribeir\u00e3o Preto, Ribeir\u00e3o Preto, Brazil."}], "LastName": "da Silva", "ForeName": "Cassio Prinholato", "Initials": "CP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Ribeir\u00e3o Preto, Ribeir\u00e3o Preto, Brazil."}], "LastName": "Iglesias", "ForeName": "Bruno Benincasa", "Initials": "BB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Ribeir\u00e3o Preto, Ribeir\u00e3o Preto, Brazil."}, {"Identifier": [], "Affiliation": "School of Medicine, University of Ribeir\u00e3o Preto, Ribeir\u00e3o Preto, Brazil."}], "LastName": "Beleboni", "ForeName": "Ren\u00ea O", "Initials": "RO"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abbasi E., Nassiri-Asl M., Shafeei M., Sheikhi M. (2012). Neuroprotective Effects of Vitexin, a Flavonoid, on Pentylenetetrazole-Induced Seizure in Rats. Chem. Biol. Drug Des. 80 (2), 274\u2013278. \u00a010.1111/j.1747-0285.2012.01400.x", "ArticleIdList": ["10.1111/j.1747-0285.2012.01400.x", "22554436"]}, {"Citation": "Abbasi E., Nassiri-Asl M., Sheikhi M., Shafiee M. (2013). Effects of vitexin on scopolamine induced memory impairment in rats. Chin. J. Physiol. 56 (3), 184\u2013189. \u00a010.4077/CJP.2013.BAB123", "ArticleIdList": ["10.4077/CJP.2013.BAB123", "23656220"]}, {"Citation": "Benneh C., Biney R. P., Adongo D. W., Mante P. K., Ampadu F. A., Tandoh A., et al. (2018). Anxiolytic and Antidepressant Effects of Maerua angolensis DC. Stem Bark Extract in Mice. Depression Res. Treat, 1\u201318. \u00a010.1155/2018/1537371", "ArticleIdList": ["10.1155/2018/1537371", "PMC6151235", "30271633"]}, {"Citation": "Beyenburg S., Mitchell A. J., Schmidt D., Elger C. E., Reuber M. (2005). Anxiety in patients with epilepsy: Systematic review and suggestions for clinical management. Epilepsy Behav. 7 (2), 161\u2013171. \u00a010.1016/j.yebeh.2005.05.014", "ArticleIdList": ["10.1016/j.yebeh.2005.05.014", "16054870"]}, {"Citation": "Bhandage A. K., Jin Z., Hellgren C., Korol S. V., Nowak K., Williamsson L., et al. (2017). AMPA, NMDA and kainate glutamate receptor subunits are expressed in human peripheral blood mononuclear cells (PBMCs) where the expression of GluK4 is altered by pregnancy and GluN2D by depression in pregnant women. J. Neuroimmunol. 305, 51\u201358. \u00a010.1016/j.jneuroim.2017.01.013", "ArticleIdList": ["10.1016/j.jneuroim.2017.01.013", "28284346"]}, {"Citation": "Bialer M., White H. S. (2010). Key factors in the discovery and development of new antiepileptic drugs. Natural Rev. Drug Discovery 9, 68\u201382. \u00a010.1038/nrd2997", "ArticleIdList": ["10.1038/nrd2997", "20043029"]}, {"Citation": "Can O. D., Demir Ozkay U., Ucel U. I. (2013). Anti-depressant-like effect of vitexin in BALB/c mice and evidence for the involvement of monoaminergic mechanisms. Europen J. Pharmacol. 699, 250\u2013257. \u00a010.1016/j.ejphar.2012.10.017", "ArticleIdList": ["10.1016/j.ejphar.2012.10.017", "23099258"]}, {"Citation": "Canevini M. P., Sarro G., Galimberti C. A., Gatti G., Liccheta L., Malerba A., et al. (2010). Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 51 (5), 797\u2013804. \u00a010.1111/j.1528-1167.2010.02520.x", "ArticleIdList": ["10.1111/j.1528-1167.2010.02520.x", "20545754"]}, {"Citation": "Colas D., Chuluun B., Warrier D., Blank M., Wetmore D. Z., Buckmaster P., et al. (2013). Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down\u2019s syndrome. Br. J. Pharmacol. 169 (5), 963\u2013973. \u00a010.1111/bph.12169", "ArticleIdList": ["10.1111/bph.12169", "PMC3696321", "23489250"]}, {"Citation": "Diniz T. C., J\u00fanior R. G. O., Medeiros M. A. M. B., Silva M. G., Teles R. B. A., Menezes P. P., et al. (2019). Anticonvulsant, sedative, anxiolytic and antidepressant activities of the essential oil of Annona vepretorum in mice: Involvement of GABAergic and serotonergic systems, (2019). Biomed. Pharmacother. 111, 1074\u20131087. \u00a010.1016/j.biopha.2018.12.114", "ArticleIdList": ["10.1016/j.biopha.2018.12.114", "30841421"]}, {"Citation": "Dworetzky B. A. (2017). Worrying More about Anxiety in Patients with Epilepsy. Epilepsy Curr. 17 (6), 353\u2013354. \u00a010.5698/1535-7597.17.6.353", "ArticleIdList": ["10.5698/1535-7597.17.6.353", "PMC5706354", "29217976"]}, {"Citation": "England M. J., Liverman C. T., Schultz A. M., Strawbridge L. M. (2012). Epilepsy across 455 the spectrum: Promoting health and understanding. Epilepsy Behav. E&B 25 (2), 266\u2013276. \u00a010.1016/j.yebeh.2012.06.016", "ArticleIdList": ["10.1016/j.yebeh.2012.06.016", "PMC3548323", "23041175"]}, {"Citation": "Fisher P. L., Noble A. J. (2017). Anxiety and depression in people with epilepsy: The contribution of metacognitive beliefs. Seizure 50, 153\u2013159. \u00a010.1016/j.seizure.2017.06.012", "ArticleIdList": ["10.1016/j.seizure.2017.06.012", "28667910"]}, {"Citation": "Funchal C., Dani C. (2014). Neurosci\u00eancias: Modelos Experimentais Animais. EdiPUCRS, 280."}, {"Citation": "Gandy M., Sharpe L., Perry K. N., Miller L., Thayer Z., Boseiro J., et al. (2015). Anxiety in epilepsy: a neglected disorder. J. Psychosom. Res. 78, 149\u2013155. \u00a010.1016/j.jpsychores.2014.12.002", "ArticleIdList": ["10.1016/j.jpsychores.2014.12.002", "25541120"]}, {"Citation": "Gauthier I., Nuss P. (2015). Anxiety disorders and GABA neurotransmission: a\u00a0disturbance of modulation. Neuropsychiatr. Dis. Treat. 11, 165\u2013175. \u00a010.2147/NDT.S58841", "ArticleIdList": ["10.2147/NDT.S58841", "PMC4303399", "25653526"]}, {"Citation": "Guimar\u00e3es C. C., Oliveira D. D., Valdevite M., Fachin A. L. S., Pereira S. I. V., Fran\u00e7a S. C., et al. (2015). The glycosylated flavonoids vitexin, isovitexin, and quercetrin isolated from Serjania erecta Radlk (Sapindaceae) leaves protect PC12 cells against amyloid-beta peptide-induced toxicity. Food Chem. Toxicol. 86, 88\u201394. \u00a010.1016/j.fct.2015.09.002", "ArticleIdList": ["10.1016/j.fct.2015.09.002", "26385725"]}, {"Citation": "Guina J., Merrill B. (2018). Benzodiazepines I: Upping the Care on Downers. J. Clin. Med. 7 (2), 1\u201322. \u00a010.3390/jcm7020017", "ArticleIdList": ["10.3390/jcm7020017", "PMC5852433", "29385731"]}, {"Citation": "Hanrahan J. R., Chebib M., Johnston G. A. R. (2011). Flavonoid modulation of GABAA receptors. Br. J. Pharmacol. 163 (2), 234\u2013245. \u00a010.1111/j.1476-5381.2011.01228.x", "ArticleIdList": ["10.1111/j.1476-5381.2011.01228.x", "PMC3087128", "21244373"]}, {"Citation": "Hascoet M., Bourin M. (1998). A new approach to the light/dark procedure in mice. Pharmacol. Biochem. Behav. 60, 645\u2013653. \u00a010.1016/s0091-3057(98)00031-8", "ArticleIdList": ["10.1016/s0091-3057(98)00031-8", "9678648"]}, {"Citation": "He M., Min J. W., Kong W. L., He X. H., Li J. X., Peng B. W. (2016). A review on the pharmacological effects of vitexin and isovitexin. Fitoterapia 115, 74\u201385. \u00a010.1016/j.fitote.2016.09.011", "ArticleIdList": ["10.1016/j.fitote.2016.09.011", "27693342"]}, {"Citation": "Kazdoba T. M., Hagerman R. J., Zolkowska D., Rogawski M. L. A., Crawley J. N. (2015). Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology 233, 309\u2013323. \u00a010.1007/s00213-015-4115-7", "ArticleIdList": ["10.1007/s00213-015-4115-7", "PMC4703522", "26525567"]}, {"Citation": "Kwon O., Park S. (2014). Depression and Anxiety in People with Epilepsy. J. Clin. Neurol. 10 (3), 175\u2013188. \u00a010.3988/jcn.2014.10.3.175", "ArticleIdList": ["10.3988/jcn.2014.10.3.175", "PMC4101093", "25045369"]}, {"Citation": "L\u00f6scher W. (2011). Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20 (5), 359\u2013368. \u00a010.1016/j.seizure.2011.01.003", "ArticleIdList": ["10.1016/j.seizure.2011.01.003", "21292505"]}, {"Citation": "Martin E., II, Ressler K. J., Binder E., Nemeroff C. B. (2009). The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and pychoneuroendocrinology. Psychiatr. Clinics North America 32 (3), 549\u2013575. \u00a010.1016/j.psc.2009.05.00", "ArticleIdList": ["10.1016/j.psc.2009.05.00", "PMC3684250", "19716990"]}, {"Citation": "Masneuf S., Lowery-Gionta E., Colacicco G., Pleil K. E., Li C., Crowley N., et al. (2014). Glutamatergic mechanisms associated with stress-induced amygdala excitability and anxiety-related behavior. Neuropharmacology 85, 190\u2013197. \u00a010.1016/j.neuropharm.2014.04.015", "ArticleIdList": ["10.1016/j.neuropharm.2014.04.015", "PMC4170856", "24796255"]}, {"Citation": "Miroddi M., Calapai G., Navarra M., Minciullo P. L., Gangemi S. (2013). Passiflora incarnata L.: Ethnopharmacology, clinical application, safety and evaluation of clinical trials. J. Ethnopharmacol. 150 (3), 791\u2013804. \u00a010.1016/j.jep.2013.09.047", "ArticleIdList": ["10.1016/j.jep.2013.09.047", "24140586"]}, {"Citation": "Moto F. C. O., Arsa\u2019a A., Ngoupaye G. T., Taiwe G. S., Njapdounke J. S. K., Kandeda A. K., et al. (2018). Anxiolytic and Antiepileptic Properties of the Aqueous Extract of Cissus quadrangularis (Vitaceae) in Mice Pilocarpine Model of Epilepsy. Front. Pharmacol. 9, 751. \u00a010.3389/fphar.2018.00751", "ArticleIdList": ["10.3389/fphar.2018.00751", "PMC6056655", "30065650"]}, {"Citation": "Nassiri-Asl M., Shariati-Rad S., Zamansoltani F. (2007). Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement. Altern. Med. 7. \u00a010.1186/1472-6882-7-26", "ArticleIdList": ["10.1186/1472-6882-7-26", "PMC1973074", "17686156"]}, {"Citation": "Oliveira D. R., Zamberlam C. R., Gaiardo R. B., R\u00eago G. M., Cerutti J. M., Cavalheiro A. J., et al. (2014). Flavones from Erythrina falcata are modulators of fear memory. BMC Complement. Altern. Med. 14 (1), 1\u201317. \u00a010.1186/1472-6882-14-288", "ArticleIdList": ["10.1186/1472-6882-14-288", "PMC4141959", "25096710"]}, {"Citation": "Oliveira D. R., Todo A. H., R\u00eago G. M., Cerutti J. M., Cavalheiro A. J., Rando D. G. G., et al. (2018). Flavones-bound in Benzodiazepine Site on GABA A Receptor: Concomitant Anxiolytic-Like and Cognitive-Enhancing Effects Produced by Isovitexin and 6-C-glycoside-Diosmetin. Eur. J. Pharmacol. 15 (831), 77\u201386. \u00a010.1016/j.ejphar.2018.05.004", "ArticleIdList": ["10.1016/j.ejphar.2018.05.004", "29738701"]}, {"Citation": "Pellow S., Chopin P., File S. E., Briley M. (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149\u2013167. \u00a010.1016/0165-0270(85)90031-7", "ArticleIdList": ["10.1016/0165-0270(85)90031-7", "2864480"]}, {"Citation": "Pinel J. P., Rovner L., II (1978). Electrode pacement and kindling: induced experimental epilepsy. Exp. Neurol. 58 (15), 35\u2013346-202. \u00a010.1016/0014-4886(78)90145-0", "ArticleIdList": ["10.1016/0014-4886(78)90145-0", "618751"]}, {"Citation": "Ramos A., Pereira E., Martins G. C., Wehrmeister T. D., Izidio G. S. (2008). Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav. Brain Res. 193, 277\u2013288. \u00a010.1016/j.bbr.2008.06.007", "ArticleIdList": ["10.1016/j.bbr.2008.06.007", "18590774"]}, {"Citation": "Salpekar J. A., Mula M. (2018). Common psychiatric comorbidities in epilepsy: How big of a problem is it? Epilepsy Behav. 18, 1\u20135. \u00a010.1016/j.yebeh.2018.07.023", "ArticleIdList": ["10.1016/j.yebeh.2018.07.023", "30149996"]}, {"Citation": "Walf A. A., Frye A. C. (2007). The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322\u2013328. \u00a010.1038/nprot.2007.44", "ArticleIdList": ["10.1038/nprot.2007.44", "PMC3623971", "17406592"]}, {"Citation": "\nWorld Health Organization  (2019. a). Epilepsy key facts. Available at: https://www.who.int/news-room/fact-sheets/detail/epilepsy (Accessed October 04, 2019).\n"}, {"Citation": "\nWorld Health Organization  (2019. b). Epilepsy: a public health imperative. Available at: https://www.who.int/mental_health/neurology/epilepsy/report_2019/en/ (Accessed October 15, 2019).\n"}, {"Citation": "Wu Q., Zhao C. W., Long Z., Xiao B., Feng L. (2018). Anatomy Based Networks and Topology Alteration in Seizure-Related Cognitive Outcomes. Front. Neuroanat. 12, 25. \u00a010.3389/fnana.2018.00025", "ArticleIdList": ["10.3389/fnana.2018.00025", "PMC5898178", "29681801"]}, {"Citation": "Yuen E. S. M., Troconiz I. F. (2015). Can pentylenetetrazole and maximal electroshock rodent seizure models quantitatively predict antiepileptic efficacy in humans? Seizure 24, 21\u201327. \u00a010.1016/j.seizure.2014.11.006", "ArticleIdList": ["10.1016/j.seizure.2014.11.006", "25564315"]}, {"Citation": "Zemdegs J., Rainer Q., Grossmann C. P., Rousseau-Ralliard D., Grynberg A., Ribeiro E., et al. (2018). Anxiolytic- and Antidepressant-Like Effects of Fish Oil-Enriched Diet in Brain-Derived Neurotrophic Factor Deficient Mice. Front. Neurosci. 12:2018.00974. \u00a010.3389/fnins.2018.00974", "ArticleIdList": ["10.3389/fnins.2018.00974", "PMC6308198", "30622454"]}]}], "History": [{"Year": "2020", "Month": "2", "Day": "4"}, {"Year": "2020", "Month": "7", "Day": "20"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "8", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["32848784", "PMC7431698", "10.3389/fphar.2020.01181"]}}]}